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ABBREVIATIONS 
pNPP, para-Nitrophenyl phosphate; 
Tyr-P, (L)-Tyrosine phosphate; 
pNPS, para-Nitrophenvl sulfate; 
EGTA, Ethylene glycol bis(g-amino ethyl ether)N/N'-
tetraacetate; 
HPLC, High Performance Liquid Chromatography; 
F-Tyr-P, (DL)-3-Fluorotyrosine phosphate; 
F^-Tyr-P, (DL)-2,3,5,6-Tetrafluorotyrosine; 
Pi, Inorganic phosphate; 
pNP, para-Nitro phenol; 
MOPS, 3-(N-morpholino)propanesulfonic acid; 
LG, Phenolic leaving group; 
PFP, Pentafluorophenol; 
MES, 3-(N-morpholino)ethanesulfonic acid; 
PIPES, piperazine-N,N'-bis(2-ethanesulfonic acid); 
HEPES, N-2-hydroxyethyIpiperazine-N'-2-ethanesulfonic acid; 
TRICINE, N-[tris-(hydroxy)methyl] glycine; 
BICINE, N,N-bis(2-hydroxyethyl)glycine; 
tris, tris-(hydroxymethyl)aminomethane; 
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INTRODUCTION 
The regulation of protein function via enzyme catalyzed 
covalent modification reactions provides a sensitive, 
reversible mechanism for metabolic control (1,2). A number 
of covalent modifications have been identified (3,4). Among 
the most studied is cyclic phosphorylation-dephosphorylation 
(5-8) of serine or threonine residues in proteins in 
response to hormonal or neural stimuli. Phosphorylation-
dephosphorylation of enzymes on these residues has been 
implicated in the regulation of glycogen metabolism (9-11), 
glycolysis/gluconeogenesis (12-15), lipid metabolism (16-
19), protein synthesis (20,21), muscle contraction (22,23), 
and neurotransmitter synthesis (24,25). A number of other 
systems, involving phosphorylation-dephosphorylation, are 
known for which the precise role of the modification is not 
well defined (26-28).. A compilation of the enzymes known to 
be regulated by phosphorylation-dephosphorylation has 
recently been put together (29,30). 
A number of the enzymes, protein kinases, responsible 
for the phosphorylation events have been isolated and 
characterized. These kinases can be classified (31,32) upon 
the basis of the regulatory mechanisms that each is subject 
to. These enzymes have been extensively characterized with 
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respect to their biological activators and inhibitors, 
structural features, and their regulation by phosphorylation 
as discussed in a number of recent review and research 
articles (25,33-53). The substrate specificity determinants 
as identified with peptide substrates have been extensively 
examined (34,54-71). One of these enzymes, the cAMP-
dependent protein kinase, has been additionally 
characterized with regards to mechanistic features (72-76) 
of the catalyzed reaction. 
Comparatively, much less is known about the enzymes, 
phosphoprotein phosphatases, responsible for the hydrolysis 
of the protein phosphate ester. Phosphatase activities 
involved in the regulation of the various metabolic proces­
ses indicated earlier have been described (77-81). 
Phosphoprotein phosphatases have been isolated by a number 
of different protocols from a variety of sources. This 
diversity has provided a great deal of confusion along with 
a vast amount of factual knowledge concerning these 
phosphatases (82-84). Ingebritsen and Cohen have tried to 
systematize the field of phosphatases with the development 
of a classification scheme (77,85) primarily based upon the 
relative specificity of each phosphatase toward the a- and 
3-subunits of phosphorylase kinase and the effect of 
phosphatase inhibitor proteins. A simple explanation of the 
TABLE I 
Classification of Phosphoprotein Phosphatases* 
Type 
Inhibition by 
Inhibitor Proteins 
Specificity 
Phos Kinase Substrate 
Phos phosphatase 
Activity 
Other 
Effectors 
1 Yes P-subunit Broad High GSK-3 
2A No a-subunit Broad High Polycations 
2B No a-subunit Narrow Low Ca=^/CaM 
2C No a-subunit Broad Low Mg=" 
"The table is adapted from Ingebritsen and Cohen (85). 
scheme is depicted in Table I. The phosphatases included in 
this scheme can account for the majority of phosphatase 
activity involved in the regulation of metabolic pathways 
(77-81,85). 
Much confusion in the study of the various phosphatases 
has arisen because of the difficulty in obtaining 
homogeneous preparations of the enzymes. Extensive 
investigations have generated disagreement concerning the 
size and subunit structure of the native, catalytically 
active form of the best known phosphatase, phosphorylase 
phosphatase (86-94). Multiple forms (95-100) of this enzyme 
have been isolated. In general, phosphatases are less well 
characterized than are kinases. For example, while acceptor 
specificity determinants of kinases are reasonably well 
defined, there are only a few reports of the specificity 
determinants of protein phosphatases as determined with 
peptide substrates (71,101-104); moreover, these have not 
been accomplished as systematically as in the situation of 
the kinase studies. 
It is well established that phosphatase 1, or 
phosphorylase phosphatase, is subject to hormonal regulation 
(82,105-108). These hormonal effects on phosphatase 1 are 
modulated through the function of one of the two phosphatase 
inhibitor proteins specific for this phosphatase. 
Inhibitor-2 is postulated to be a subunit in the inactive 
complex of phosphatase-1 (109). The other phosphatases, 
phosphatases 2A, 2B, and 2C, described in Table I are not 
regulated by these inhibitor proteins. Phosphatase 2A is 
modulated by polycationic compounds (110-113), including 
histone I, spermine, and putrescine, but little is known of 
the mechanism or physiological significance of this process. 
Phosphatase 2C has not been investigated extensively (85). 
The properties and regulation of phosphatase 2B, or 
calcineurin, will be discussed in additional detail later. 
Recently, the phosphorylation of protein tyrosine 
residues was observed in proteins of cells transformed by 
tumor viruses (114-124). Quickly, this modification has 
been identified in preparations of receptors of growth 
factors (125-133) after treatment with the appropriate 
growth factor as well as in cellular proteins following the 
treatment of a responsive cell with a growth factor. A 
number of nontreated and nontransformed cells have been 
shown to possess tyrosine kinase activity (134-141). The 
field of tyrosine phosphorylation has blossomed in the past 
5 years to rival that of the extensively studied serine 
phosphorylation systems. 
A great deal has been determined about the protein 
kinases responsible for the phosphorylation of tyrosine 
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residues (142-147). The viral enzymes are found to be 
identical with the product (114-124,148) of the gene 
responsible for transformation, the oncogene. General 
properties of these enzymes include a requirement for Mg^* 
or Mn^"^ and a preference for ATP over OTP as a phosphoryl 
donor (117,119,120,122,130,149-154), the possession of 
autophosphory1at ion activity (117,120,154-160), and an 
apparent requirement for acidic residues amino terminal to 
the tyrosine residue to be modified (158,161-165), although 
further examination of specificity determinants utilizing 
peptide substrates (164,166-171) has not provided confirming 
information. Comparisons of tryptic peptide maps (172,173) 
and predicted amino acid sequences (174,175) reveal 
significant homology amongst these enzymes as well as 
homology to serine kinases (175). 
Initially, the observation that levels of tyrosine 
phosphate in proteins were elevated in cellular proteins 
isolated from viral transformed cells was interpreted to 
indicate a role for tyrosine phosphorylation in the 
initiation and maintenance of the transformed state 
(156,176-179). Additional study has not supported this 
hypothesis (180,181). Current speculation postulates a 
significant role for tyrosine phosphorylation in growth 
control (182,183). This speculation is supported by the 
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observation that cell lines which do not respond well to 
epidermal growth factor also fail to demonstrate the 
activation of tyrosine kinase activity in the EGF receptor 
upon treatment of the cell with EGF (184). An increase in 
tyrosine kinase activity has also been reported to occur 
upon fertilization (185,186), during development (187-189) 
and upon differentiation (190,191) in a number of cell 
types. These observations suggest that tyrosine 
phosphorylation may be a signal for cell growth. The 
increased levels in viral transformed cells may reflect a 
mechanism for these cells to withstand intercellular signals 
preventing growth. The transformed cells are then free to 
undergo uncontrolled growth as is observed in the culture of 
transformed cells. 
To be a physiologically significant regulatory 
mechanism, the modification reaction must be reversible. 
The field of phosphotyrosy1-protein phosphatase is as 
complex as the study of phosphoseryl-protein phosphatases. 
Phosphatases specific for the hydrolysis of phosphotyrosy1 
residues in proteins have been isolated from a number of 
sources including rabbit kidney (192), rat brain (193), 
liver (194), and spleen (195), Ehrlich Ascites cells (196), 
A431 (human epidermoid cell line) cells (197), bovine 
cardiac muscle (198), chick embryo fibroblasts (199), and 
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chick brain (200). Activity toward phosphotyrosyl-proteins 
has also been identified in preparations of the nonspecific 
acid (201-204) and alkaline (204,205) phosphatases and in 
preparations of a phosphoseryl-protein phosphatase (206) 
from cardiac muscle. In fact, the nonspecific phosphatases 
seemingly dephosphorylate phosphotyrosyl phosphoproteins 
more readily than phosphoseryl phosphoproteins 
(201,203,205). 
As with the phosphorylation of serine/threonine 
residues, the phosphatases involved in the hydrolysis of 
phosphotyrosyl residues are less well characterized than the 
tyrosine protein kinases. The field remains, as yet, at the 
stage of simply the identification of activities. General 
features which have emerged, as reviewed (207,208), indicate 
that these enzymes are sensitive to inhibition by micromolar 
Zn^^ (197), sensitive to inhibition by vanadate (209), less 
sensitive to inhibition by fluoride than are phosphoseryl-
phosphatases, stimulated by EDTA, and possesses maximum 
activity in the pH range 6.0-7.0. 
Of particular interest is the calmodulin-activated 
phosphatase, calcineurin, due to its ability to 
dephosphorylate phosphoproteins containing each of the 
phospho hydroxy-amino acids (210). The phosphoproteins 
which have been shown to serve as substrates for calcineurin 
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are listed in Table II (210-218). Also included in this 
table are the residues from which the phosphoryl moiety is 
removed. Calcineurin is observed to have a broad 
specificity toward the phospho hydroxy-amino acid residue of 
the substrate phosphoprotein while dephosphorylating a 
limited number of proteins. The mechanistic determinants of 
this feature of calcineurin remain unknown. It is, as yet, 
unclear what the relative importance of the phosphotyrosyl 
and phosphoseryl phosphoprotein phosphatase activities of 
calcineurin are. 
Tissue distribution (219) studies indicate that the 
enzyme is preferentially found within neural tissues. The 
highest levels occur in the cerebrum, olfactory bulb, and 
the cerebellum; the cerebrum contains the highest amounts. 
Within the cerebrum, calcineurin is primarily located in the 
caudate nucleus and the putamen. Further localization (220) 
has indicated that calcineurin is associated with the post­
synaptic densities and dendritic microtubules within the 
dendrites. Calmodulin follows a similar distribution 
pattern (220). In chick retina (221), calcineurin is found 
localized to both pre- and post-synaptic densities. In 
agreement with these findings, a developmental study (222) 
of calmodulin-dependent phosphatase in rat and chick nervous 
tissues has revealed that levels of the enzyme increase 
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TABLE II 
Phosphoprotein Substrates for Calcineurin 
Protein Residue 
Inhibitor-1 Thr 
G-Substrate Thr 
DARPP-32 Thr 
Phosphorylase Kinase Ser 
R II Subunit Kinase A Ser 
Myosin Light Chain Ser 
Protein K.-F. Ser 
Synapsin-I Ser 
Casein Ser,Tyr 
EGF R/K Tyr 
Histone Hl nd" 
"nd, not determined. 
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during synaptogenesis. 
Calcineurin is primarily isolated from bovine brain 
(223-228). Calmodulin-dependent phosphoprotein phosphatase 
activity has also been isolated from human platelets (229), 
skeletal muscle (213,230), pancreas (231), rat brain (215), 
cardiac muscle (216,232), erythrocytes (233), reticulocytes 
(234)', rabbit brain (235), sea urchin (236), Xenopus oocytes 
(237), and Paramecium tetraurelia (238). The brain is found 
to have the highest levels of the protein as already 
discussed. The physical properties of these enzymes that 
have been determined are found to be similar to the bovine 
brain form, calcineurin. 
Calcineurin was first isolated (223-228) as a 
calmodulin binding protein of molecular weight 80,000 and 
designated as CBP80. It was initially assayed by its 
ability to inhibit the activation of phosphodiesterase (223-
228) and adenylate cyclase (226,227) by calmodulin (then 
known as the Ca®* dependent activator protein). It was 
later shown to possess phosphatase activity toward a number 
of phosphoproteins (212,213). As isolated from bovine 
brain, calcineurin is a heterodimer of 80,000 molecular 
weight with subunits of 61,000 and 19,000 kilodaltons 
(225,227,228,239). The larger. A, subunit is the catalytic 
subunit (239-243) and possesses binding sites for calmodulin 
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(223,228,239,244,245) and divalent metal ions (241,246,247). 
The smaller, B, subunit possesses 4 binding sites for Ca^^ 
(225,239,245,248) with a = 1.0 X 10"® M and is 
myristylated at its amino terminal residue (248,249). The 
B- subunit shares a fairly high degree of homology (35%) 
with bovine brain calmodulin (248,250). The function of the 
B-subunit is not definite, but appears to serve a regulatory 
role (245,251,252). Removal of the B-subunit from the 
holoenzyme leaves an active A-subunit (240,241,251,252). 
The catalytic activity of the isolated A-subunit is 
stimulated by both calmodulin and the B-subunit (251,252). 
The B-subunit activates the activity of the A-subunit 
greater than does calmodulin (251). Activity is 
synergistically stimulated in the presence of both 
calmodulin and the B-subunit (251). 
The enzymatic properties of calcineurin are just 
beginning to be elucidated. Calmodulin activates the enzyme 
5-10 fold (212,213,240,241,251-255). The activation is due 
to an increase in VM with little change in the KM value for 
the substrate (251,253-255). The activation process 
involves the binding of 2 metal ions (Ca^*) to calmodulin 
which permits the interaction of calmodulin with the 
phosphatase (256). . Additional binding of metal ions (Ca^*) 
produces activation of the enzyme. Calmodulin also induces 
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the deactivation of the phosphatase activity of calcineurin 
(257,258) upon prolonged incubation. This deactivation 
cannot be reversed by the dissociation of calmodulin, but 
the enzyme can be reactivated by the addition of metal ion 
in the presence of calmodulin (257). 
The phosphatase activity of calcineurin is dependent 
upon the presence of a divalent metal ion (255,257-263); 
Mn^* and Ni®* support the highest activity although other 
metals activate the enzyme to some extent. It might be 
expected that the B-subunit is responsible for the metal ion 
activation; however, the A-subunit is known to bind 2 Ni^* 
ions (246,247) suggesting that the catalytically active 
metal binds the catalytic subunit. It has been reported 
that calcineurin contains tightly bound metals, identified 
as Mn (260) or Fe and Zn (257). The subunit in which these 
metals are found is not known. The activation by metal ions 
is thought to be via the inducement of a conformational 
change in the protein (255,262,263). Support for a metal 
ion dependent conformational change, particularly in the B-
subunit, has been obtained from studies of the interaction 
of subunit specific antibodies with calcineurin (264). It 
has recently been shown that activation of calcineurin 
activity is directly correlated to the binding of metal ion 
(247) . 
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Calcineurin has been shown to be a substrate for both 
the Ca^•••-activated, phospholipid-dependent protein kinase 
(265) and a carboxylroethyl transferase (266). 
Phosphorylation has no effect on the in vitro activity of 
calcineurin whereas methylation appears to have no effect on 
the basal activity (Mn^* dependent) of the enzyme while 
reducing the calmodulin stimulated activity. The 
physiological effects of these modifications remain unknown. 
Trypsinization (242,243) produces an active fragment of the 
A-subunit which is not sensitive to calmodulin. 
Fallen and Wang (267) determined that calcineurin 
possessed activity toward the low-molecular-weight phosphate 
esters, para-nitrophenvl phosphate and free tyrosine 
phosphate. Subsequently, naphthyl phosphates and 
phosphoenolpyruvate and other "activated phosphates" have 
been shown to be hydrolyzed by calcineurin (262,268). A 
number of other biological"esters such as phosphoserine, 
phosphothreonine, glucose-6-phosphate, and nucleotide 
phosphates are not substrates for calcineurin (262,268). 
These low-molecular-weight esters are hydrolyzed with both a 
higher VM and a higher KM (mM) than phosphotyrosyl 
phosphoproteins (214,217,254,255,262). 
The preceding discussion serves to illustrate the 
enormous amount of information that has been acquired 
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concerning the enzymes involved in protein phosphorylation-
dephosphorylation. However, little is known concerning the 
features of the chemistry involved in the catalytic 
reactions. Detailed information about the chemical 
mechanism involved in protein phosphorylation been 
determined for only one kinase and not at all for 
phosphoprotein-specific phosphatases, although the non­
specific phosphatases have been well characterized with 
respect to their chemical mechanisms (269-271). 
Calcineurin is clearly the most well defined specific 
phosphoprotein phosphatase, but still little is known of the 
mechanism of action of this enzyme. The focus of this 
research has been to determine features of mechanism of 
action of calcineurin. We have exploited the low-molecular-
weight phosphatase activity of calcineurin as a model 
enzymatic reaction to examine features of the chemistry of 
calcineurin catalysis as well as potential information of 
the chemistry involved in the dephosphorylation of 
phosphotyrosyl residues. Although it seems clear that the 
activity of calcineurin toward these esters is of little 
physiological significance, it enables specific, 
characterizable changes in the structure of the substrate. 
The approach we have utilized entails the application of 
tyrosine phosphate derivatives in which a substituent in the 
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aryl ring, primarily fluorine atoms, is incorporated. The 
substrates utilized are shown in Figure 1. Replacement of 
hydrogen with fluorine is interesting because of the 
introduction of a highly electronegative atom without the 
introduction of steric effects common with other 
substituents; Application of principles from physical 
organic chemistry and observations from model chemical 
reactions coupled with investigations of the enzymatic 
properties of the reaction provide powerful insights into 
the chemical mechanism of calcineurin and phosphotyrosyl 
dephosphorylation. The results of these studies may prove 
useful for the development of potential inhibitors of 
phosphotyrosyl protein phosphatases. The majority of these 
results have been published (272,273). 
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Figure 1. Low-molecular-weight substrates for calcineurin 
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EXPERIMENTAL PROCEDURES 
Materials - Escherichia coli alkaline phosphatase, 
potato acid phosphatase, disodiuia para-nitrophenvl phosphate 
(Sigma 104 substrate), 3-nitrotryosine, 3,5-dinitrotyrosine, 
disodium para-nitrophenvl sulfate, EGTA, SP-sephadex, and 
_phenyl-sepharose were purchased from Sigma. All buffers 
utilized were also obtained from Sigma. (D,L)-3-
fluorotyrosine was obtained from either Sigma or Aldrich. 
Tetrafluorotyrosine was from Columbia Organic Chemical Co. 
and pentafluorophenol was from Aldrich. (L)-Tyrosine was 
purchased from J.T. Baker. DE-52 cellulose was from Whatman 
and Dowex 50W-X8 was from Bio-Rad. Sterox (0.02%) was from 
Harleco. All other chemicals (malachite green, metal salts, 
etc.) were obtained from Fisher. 
Synthesis of Tyrosine Phosphate - Tyrosine phosphate 
was synthesized by the method of Rothberg et al. (274). The 
yield was 116.0 mg from 1.4 g of tyrosine (5.75 % yield). 
The inorganic phosphate contamination (mol/mol) was less 
than 1%. 
Synthesis of F-Tyr-P and F^-Tyr-P - These compounds 
were synthesized from F-Tyr and F^-Tyr, respectively, 
according to Rothberg et ^ . (274). The purification was as 
follows. The fluorotyrosine phosphate reaction mixture was 
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solubillzed with ice and loaded onto a SP-sephadex column 
equilibrated with 1.0 M acetic acid and eluted with 1.0 M 
acetic acid isocratically. F-Tyr-P and Pa. eluted in the 
void while unreacted F-Tyr was retained. F-Tyr-P was 
separated from P^ on an Dltrasphere-ODS (Altex) reverse 
phase HPLC column (Ci8;1.0 X 25.0 cm) employing isocratic 
elution with 0.1% triflupracetic acid. The yield was from 
10 to 40 mg of F-Tyr-P from 300 mg starting material (2.4-
9.6% yield). F^-Tyr-P was purified in a similar fashion by 
substituting Dowex 50W-X8 for SP-sephadex with HaO as eluant 
followed by HPLC purification as before. The yield for this 
material was very low. Inorganic phosphate contamination 
was less than 1% for F-Tyr-P and less than 4% for F*-Tyr-P. 
Analysis of Synthesized Substrates - The purified Tyr-
P, F-Tyr-P, and Fa-Tyr-P all yielded a single peak on 
analytical HPLC employing isocratic elution with 0.2 M 
triethylammonium acetate, pH 6.0, on a 0.46 X 25.0 cm 
Ultrasphere-ODS reverse phase column. The peak detected was 
distinct from the respective starting material for each 
compound. Upon hydrolysis in 6 N HCl at 110"C, Tyr, F-Tyr, 
and Fa-Tyr were formed, respectively, as shown by analytical 
HPLC just described. F-Tyr and F^-Tyr hydrozylates were 
shown also to yield their respective starting materials by 
amino acid analysis. UV-VIS spectrophotometry indicated a 
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new spectrum for the phosphate ester compared with the 
starting material and showed no pH-dependent shift in the 
peak position. All three compounds were shown by ^^P-NMR to 
have only a single organic phosphate species (shifts in ppm 
relative to 85% H3PO4); Tyr-P (pH 3.0), 6=-1.85; F-Tyr-P (pH 
3.0), 6=-2.85; and F^-Tyr-P (pH 7.0), 6=3.8 ppm. F-Tyr-P 
and Fa-Tyr-P were also analyzed with ^®F-NMR. F-Tyr-P (pH 
7.0) resulted in a single peak at 6=-55.6 ppm relative to 
trifluoroacetic acid (pH 6.8), 6=0.0 ppm. F^-Tyr-P yielded 
two peaks, each a doublet, at 6=-70 ppm and 6=-80 ppm 
relative to trifluoroacetic acid. NMR spectra were obtained 
on a Bruker WM-300 NMR spectrometer operating at 121.5 and 
282.4 MHz for ®^P and ^®F, respectively. 
Preparation of Substrate Solutions - Stock solutions of 
Tyr-P and F-Tyr-P were prepared from dry solids. Alkaline 
and acid phosphatase hydrolysis of Tyr-P yielded 100% 
expected P^ release. Similar treatment of F-Tyr-P yielded 
93% and 98%, respectively, expected Pj. release. Amino acid 
analysis of the F-Tyr-P hydrozylate yielded 94% of the 
expected value. All stock solutions were used as prepared 
from dry weight with correction for P^ contamination. Stock 
solutions of Fa-Tyr-P were prepared and concentrations 
determined by amino acid analysis. 
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Enzymes - Calcineurin, isolated from bovine brain by 
the method of Sharma et al. (275) was kindly provided by Dr. 
Jerry H. Wang (Dept. of Medicinal Biochemistry, Univ. of 
Calgary, Calgary, Alberta, Canada). Calmodulin was purified 
by the procedure of Sharma and Wang (276) with a slight 
modification. Following DE-52 cellulose chromatography, the 
calmodulin was loaded onto phenyl-sepharose and eluted with 
EGTA (277). 
Assay for Inorganic Phosphate - The release of was 
assayed with a modification of a method employing malachite 
green as an indicator as developed by Hess and Derr (278). 
In general, 10-40 wl of sample were added to 30 yl 5 N HgSOa 
and enough H^O to make a final volume of 200 yl. Malachite 
green (800 yl) reagent was added; the solution was mixed, 
allowed to sit for 10 minutes, and then remixed. The 
absorbance of the solution was then measured at 660 nm. The 
malachite green was prepared as follows: 3 volumes Of 
0.045% malachite green in HgO was mixed with 1 volume Of 
4.2% ammonium molybdate in 4 N HCl. This mix was stirred 
for 30 minutes followed by the addition of 1.0 ml 0.02% 
sterox for each 50 ml of dye solution. The solution was 
then filtered and ready for use. A standard curve was 
linear over the range 0.5-8.0 nmol of Pi, with a typical 
extinction coefficient of 0.085 Aeeo/nmol P^. Typically, 
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the reagent was good for 1-2 weeks if stored in the cold. 
No interference by buffers, metal ions, proteins, or 
substrates and products of the reactions on the accuracy and 
reproducibility of the assay was observed. 
Assay for para-Nitrophenol - The formation of para-
nitrophenol was followed at 410 nm. Reaction aliquots were 
diluted to 1.0 ml with 0.1 M glycine, pH 9.5, mixed, and the 
absorbance measured at 410 nm. An extinction coefficient of 
1.73 X 10"* M~^ cm-i was employed for pNP. 
Assay for Protein - Acid phosphatase, calmodulin, and 
calcineurin were all measured by the method of Bradford 
(279). Alkaline phosphatase was measured by employing an 
eigo=7.2 (280). 
Alkaline Phosphatase Assay - Alkaline phosphatase 
assays were carried out in 10 mM glycine, pH 9.5, 1 mM MgCla 
and 0.1 mM ZnClg at 30*C. Initial rate kinetics were 
followed spectrophotometrically in a reaction volume of 1.25 
ml. Dephosphorylation of Tyr-P was followed at 285 nm by 
measuring the appearance of tyrosine by employing an 
6283=607 M~^ cm-i. Hydrolysis of F-Tyr-P was performed at 
290 nm by using an £2BO=1970 M~^ cm~^ for F-Tyr. The amount 
of enzyme used in each assay was 0.5 yg. The time course 
was generated by removing 10 yl aliquots from a 100 yl 
mixture for the measurement of inorganic phosphate. The 
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enzyme level was 3.0 vg/ml. 
Acid Phosphatase Assays - Assays were done in a 
reaction volume of 100 ill in 100 mM NaOAc, pH 4.8 at 30"C 
<281). At different intervals, 10 yl were removed and 
assayed for inorganic phosphate. The protein level was 2.3 
Vg/ml. 
Calcineurin Assays - The phosphatase activity of 
calcineurin was assayed in 25 mM MOPS, pH 7.0, 1 mM MnClg at 
30'C. Calmodulin was included at an equivalent 
concentration (yg/ml) as calcineurin. The reaction volume 
was maintained at 50 yl when assaying for the release of P^. 
whereas assays for pNP release were done in reaction volumes 
of 100 lil. Generally, activity was measured via the direct 
measurement of inorganic phosphate, the exceptions being the 
for the phosphotransferase activity and the inhibition by 
inorganic phosphate and phosphate analogs. For initial rate 
studies, 40 yl of the 50 y 1 were assayed for Ps. with Tyr-P 
and F-Tyr-P, and 20 yl for pNPP and F^-Tyr-P. With pNPP, F-
Tyr-P, and F^-Tyr-P, the reaction was linear for 6 minutes, 
whereas with Tyr-P, the reaction was linear for 15 minutes. 
Replacement of 1.0 mM MnCla with 20.0 mM MgCla did not 
affect the linearity of the reaction. Typically, initial 
rates were taken from a 3 minute reaction point for pNPP, F-
Tyr-P, and F^-Tyr-P and a 9 minute reaction point for Tyr-P. 
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Calcineurin was used at a concentration of 28 iig/ml with 
pNPP and F^-Tyr-P and 35 yg/ml with F-Tyr-P and Tyr-P. The 
extended time course was generated with a 100 jil reaction 
mix with 10 wl aliguots assayed for inorganic phosphate. 
The calcineurin concentration was 17.5 yg/ml. 
Analog Inhibitors - Inhibition by pNP, tyrosine 
derivatives, and phosphate analogs was assayed by measuring 
the amount of P^. produced. The concentrations of inhibitors 
used were 19.4-48.5 mM pNP, 10.9-43.6 mM PFP, 5.0-30.0 mM 
pNPS, and 0.5-4.0 mM for K2HPO4 and NagSO*. All tyrosine 
derivatives were tested at a concentration of 1 mM because 
of solubility constraints and for comparison with the 
inhibition by Pa. at 1 mM. 
Inhibition Kinetics - All inhibition kinetics were 
performed in 25 mM MOPS, pH 7.0. Inhibition by P^ was 
carried out with a pNPP concentration range of 3.3-20.0 mM. 
The kinetics of the inhibition by pNP were performed in 3.5% 
ethanol to provide for pNP solubility at the levels required 
for significant inhibition. At this concentration of 
ethanol, there was a slight increase in the KM values for 
pNPP. Therefore, the range of pNPP concentrations was 
raised from 8.4 to 50.0 mM. PFP inhibition of calcineurin 
was studied over a range of 5.0 to 20.0 mM pNPP. Ethanol 
was not required for these experiments. 
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Phosphotransferase Assays - Calcineurin was assayed for 
phosphotransferase activity utilizing a reaction volume of 
100 yl with pNPP as the substrate. After a reaction time of 
3 minutes, 10 jil were assayed for Pi and the remaining 90 yl 
were assayed for pNP. 
pH Kinetics - The pH dependence of the kinetic 
parameters of calcineurin catalysis was performed utilizing 
substrate concentrations in the range 4.0-60.0 mM for pNPP 
and 3.3-20.0 mM Tyr-P. The buffer concentration was 
maintained at 25 mM. The reaction volume was maintained at 
50 yl. The effect of replacement of Mn=~ with Mg^^ on the 
kinetic parameters was measured utilizing substrate ranges 
of 8.4-50.0 mM and 3.3-20.0 mM for pNPP and Tyr-P, 
respectively. The reaction volume was maintained at 50 yl. 
pH Stability of Calcineurin Activity - Calcineurin 
(0.70 mg/ml) was incubated at each pH utilized in the 
kinetic study at 30"C in a total volume of 100 yl. The 
buffer concentration during the incubation was maintained at 
25 mM. MnCla (1 mM) and calmodulin (0.70 mg/ml) were also 
present. After incubation for 3 minutes (duration of a 
typical assay), 4 yl were removed for assaying at pH 7.0. 
The assay volume was 100 yl, with other conditions as in the 
standard assay. 
Buffers - All assays were performed at 25 mM buffer. 
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The buffers and the pH values at which they were employed 
are: MES, 5.8, 6.1, 6.4, and 6.7; PIPES, 6.4, 6.7, 7.0, and 
7.3; MOPS, 6.7, 7.0, 7.3, and 7.6; HEPES, 7.0, 7.3, 7.6, and 
7.9; TRICINE, 7.6, 7.9, 8.2, and 8.5; and BICINE, 7.9, 8.2, 
8.5, and 8.8. Kinetics were performed in MES at pH 5.8, 
6.1, and 6.4; in MOPS at pH 7.0 and 7.6; in TRICINE at pH 
8.2; and in BICINE at pH 8.8. 
Determination of Kinetic Parameters - The parameters, 
VM/ K„, and K% were evaluated utilizing the program of Siano 
et al. (282) written in OMNITAB language. 
Determination of pK» Values - The pK» values for the 
free enzyme and enzyme-substrate complex were evaluated by 
fitting the data to the following equations (283): 
(Y)„ = Y - (Y)„ [Hr]/K. (1) 
(Y)„ = Y - K_ (Y)„/[H"] (2) 
where (Y)„ is the value of VM or VM/KM determined at each pH 
and Y is the pH independent value for the parameter. The 
pK. for the enzyme-substrate complex was evaluated from the 
VM VS. pH data set fit to equation 1. The VM/KM VS. pH data 
set was analyzed by fitting the data to equation 2. 
Acid Catalyzed Hydrolysis - The acid-catalyzed 
hydrolyses of the tyrosine phosphate analogs were carried 
out at 110"C in 6 N HCl in hydrolysis tubes. A reaction 
mixture was set up for each time point taken. Values of k»-
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were determined from plots of log (per cent remaining ester) 
versus time yielding ti/a from which is calculated from 
the relationship k„^= 0.693/ti/2. Time points taken ranged 
from 0.5 to 2.5 ti/z minimally. The concentrations employed 
were 300 yM pNPP, 222 yM Tyr-P, 227 yM F-Tyr-P, and 299 yM 
Fa-Tyr-P. 
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RESULTS AND DISCUSSION 
Both E. coli alkaline phosphatase (284) and potato acid 
phosphatase (281) are known to dephosphorylate phosphate 
esters of widely different structure with a constant VM 
value. In Figure 2, the dephosphorylation of Tyr-P and F-
Tyr-P by these two enzymes as well as by calcineurin is 
demonstrated as a function of time. Each of the two non­
specific phosphatases is seen to hydrolyze the two esters 
with the same progress curve while calcineurin apparently 
recognizes the two compounds differently. A kinetic 
investigation of the hydrolysis of these two substrates was 
performed to determine if the difference observed was merely 
an effect of KM or really a difference in Vw As seen in 
Table III, alkaline phosphatase hydrolyzed both compounds 
with essentially the same VM, as expected. In contrast to 
this observation, calcineurin was observed to hydrolyze F-
Tyr-P much more readily than Tyr-P. 
A further investigation of the kinetic parameters of 
calcineurin with the other substrates given in Figure 1 
reveal that calcineurin, indeed, does not seem to hydrolyze 
these phosphate esters with a constant maximum velocity. 
The kinetic parameters of calcineurin are compiled in Table 
IV. This initial observation suggests that, unlike the non-
Figure 2. Progress curve for the hydrolysis of Tyr-P and 
F-Tyr-P. The substrates were hydrolyzed by E. 
coli alkaline phosphatase ( , ), potato acid 
phosphatase ( , ), and calcineurin ( , ) at pH 
7.0. In all cases, the substrate concentration 
is lOmM. Open symbols represent the hydrolysis 
of Tyr-P and closed symbols represent the 
hydrolysis of F-Tyr-P. Other details are given 
in the "Experimental Procedures" section 
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TABLE III 
Comparison of Hydrolysis of Tyr-P and F-Tyr-P by 
Alkaline Phosphatase and Calcineurin* 
Alkaline Phosphatase Calcineurin 
Substrates v»» KM° VM»» 
Tyr-P 1.16+0.06 47.9+7.5 0.39+0.03 6.2 + 0.7 
F-Tyr-P 1.52+0.13 93.6+20.9 1.93+0.2 4.2+0.7 
"Amounts of enzyme used were; 1.75 yg calcineurin and 
0.5 yg alkaline phosphatase. 
is given units of 10"® M/min. 
°KM is in units mM for calcineurin catalyzed hydrolysis 
and yM for alkaline phosphatase. 
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TABLE IV 
Kinetic Parameters for Calcineurin-catalyzed Hydrolysis 
Substrate pK. LG 
Relative 
v„- KM (mM) 
Relative 
VM/K„ 
Tyr-P 10.07» 0.030+0.003 6.20+0.7 0.048+0.002 
F-Tyr-P 9.21= 0.14+0.02 4.20+0.7 0.35+0.02 
pNPP 7.14* 1.00+0.1 10.1+1.4- 1.00+0.1 
Fa-Tyr-P 5.40* 0.29+0.07 1.7+0.6 2.50+0.4 
"Corrected for the amount of enzyme (1.75 vg/assay for 
F-Tyr-P and Tyr-P, 1.4 vg/assay for pNPP and F^-Tyr-P) added 
in assay. For comparison, the VM with pNPP is 3.7 
ymol/min/mg enzyme. 
''Reference 285. 
"Reference 286. 
^Reference 287. 
"The value of KM (pNPP) = 14.4 mM in kinetic 
experiments utilizing F*-Tyr-P. The value VM/KM (F^-Tyr-P) 
is corrected for this difference. 
^Reference 288. 
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specific acid (289) and alkaline (290) phosphatases, 
calcineurin does not generate a phosphoryl-enzyme 
intermediate during the hydrolysis of phosphate esters. 
Figure 3 demonstrates that the maximal velocity of 
calcineurin is not independent of the leaving group in 
contrast to the situation found for the nonspecific 
phosphatases (281,284). 
The failure to observe hydrolysis of these phosphate 
esters with a constant VM suggests that the calcineurin-
catalyzed hydrolysis does not proceed with rate limiting 
decomposition of a common intermediate; that is, the rate 
limiting step in calcineurin catalysis does not involve the 
decomposition of a covalent or noncovalent phosphoryl-enzyme 
complex. Further investigation of this point was performed 
by examining whether calcineurin possessed 
phosphotransferase activity. The possession of 
phosphotransferase activity implies the existence of a 
phosphoryl-enzyme as illustrated in the reaction scheme 
given in Figure 4. The inclusion of an alcohol in the 
reaction mixture provides a second phosphoryl acceptor in 
addition to water, the normal acceptor. Phosphotransferase 
activity of calcineurin was assayed for utilizing tris or 
ethylene glycol as possible phosphoryl acceptors in 
competition with water. Tris has been shown to serve as an 
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PNP 
2.0 
F-TYR 
1.0 
TYR 
8.0 9.0 6.0 7.0 10.0 5.0 
PK, LG 
Figure 3. Dependence of log (VM) for calcxneurin catalysis 
upon the pK_ of the leaving group. The line on 
the high side of the pK^ range was generated from 
a linear regression fit of the data from Table IV 
with a correlation coefficient of -0.99 
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E + Ri-O-P E"P~0-R 1 E-P + R^OH 
Rg-O-H 
HgO 
E + Ro-O-P 
'E + P, 
Figure 4. Reaction scheme depicting the transphosphory-
lation of a competing alcohol. The reaction 
scheme presumes the formation of a phosphoryl-
enzyme as an intermediate 
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acceptor in alkaline phosphatase-catalyzed trans-
phosphorylation reactions (291), whereas ethylene glycol has 
been shown to be an acceptor in an acid phosphatase system 
(292). In the presence of either acceptor, the initial 
velocity of the calcineurin-catalyzed hydrolysis of pNPP was 
the same, independent of which product was measured as shown 
in Figure 5. That is, there was no transfer of the 
phosphoryl group to either tris or ethylene glycol. This 
supports the contention that calcineurin does not generate a 
phosphoryl-enzyme intermediate in its mechanism of action. 
The mechanistic interpretation of enzymatic reactions 
is greatly simplified by the application of physical organic 
chemistry, specifically with the aid of Brdnsted or Hammett 
plots (293). A modified BreSnsted plot is a linear free-
energy relationship in which the logarithm of the rate 
constant is related to the energy term, expressed as a pK„ 
value. The varied species may either be the incoming 
nucleophile or the leaving group. The slope term in the 
linear relationship, designated P„via or 3x,a, reflects the 
amount of bond cleavage/formation in the transition state. 
The relationship is more directly applied to the VM/KM 
term than the VM term (294). The Vm term is dependent upon 
a number of features, including accumulation of 
intermediates and nonproductive binding, which may 
Figure 5. Phosphotransferase activity of calcineurin. 
Calcineurin was assayed in the presence of 
either tris or ethylene glycol by measuring 
the release of Pj. (o) or pNP (•) . A) The 
reaction was performed in the presence of 
tris. B) The reaction was performed in the 
presence of ethylene glycol. In both 
situations, the activity of calcineurin was 
measured as described in the "Experimental 
Procedures" section 
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complicate the analysis. These features are more likely to 
cancel out in the VM/KM term. The application of Brdnsted 
plots to enzyme-catalyzed reactions is complicated, however, 
because of multiple interactions occurring within and about 
the active site of an enzyme. This effect is lessened by 
comparison of the enzymatic reaction to model chemical 
reactions of the respective substrates. Comparison of the 
3x,a values for enzymatic reactions with the for well 
defined chemical reactions, then, can reveal mechanistic 
information of the enzymatic reaction. This value, in 
conjunction with values of obtained in model studies, 
yields valuable information about the mechanism of 
calcineurin catalysis. 
As a model reaction for the enzymatic catalyzed 
hydrolyses of the tyrosine phosphate analogs utilized, the 
acid catalyzed hydrolyses of these compounds was also 
studied. As described in the Experimental Procedures, the 
kinetics of the hydrolysis of these compounds in 6 N HCl at 
110®C was investigated. Table V collects the data for this 
reaction. Figure 6 shows that the rate constant of this 
reaction is subject to a dependence upon the electronic 
properties of the compounds. 
The results of this analysis indicate that the 
specificity of calcineurin is dependent upon the nature of 
40 
TABLE V 
Kinetic Parameters for Acid-catalyzed Hydrolysis 
Substrate pK_ LG- ti/ab (min) 
Tyr-P 10.07 56.8 0.012 
F-Tyr-P 9.21 21.1 0.033 
pNPP 7.14 5.1 0.136 
Fa-Tyr-P 5.40 1.2 0.563 
"pK. values from Table IV. 
''Determined 
versus time. 
from plots of log (% remaining reactant) 
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2.0 
F^-TYR 
X je 
PNP C3 
O 1.2 
+ 
C4 
o F-TYR 
0.4 
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6.0 4.0 8.0 100 
pKo LG 
Figure 6. The dependence of log (km*) for acid-catalyzed 
hydrolysis upon the pK. of the leaving group for 
the tyrosine phosphate derivatives. The line 
shown was generated with linear regression. The 
slope of the line is -0.35. The correlation 
coefficient is -0.99. The data are from Table V 
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the substrate, particularly the phenolic leaving group. 
Figure 7 shows that, as the pK. of the resulting phenol is 
lowered, the activity of calcineurin (measured by VM/KM) is 
increased. The pK. of the phenol is also taken to be a 
measure of the lability of the phosphate ester bond. A 
similar treatment has also been done for a number of 
hydrolytic enzymes (295-300) as well as the nonenzymatic 
hydrolyses (301,302) of phosphate esters. The value for 
the calcineurin-catalyzed hydrolysis of the phosphate esters 
employed here was observed to be -0.35. This value is the 
same as the value of = -0.35 observed for the acid-
catalyzed hydrolysis of the same phosphate esters (Figure 
6). The equality of the Pt-o values for the two processes 
suggests that a relationship between the enzymatic- and 
acid-catalyzed hydrolyses exists. Figure 8 shows that there 
is a 1:1 correlation between the rate constants for the 
enzymatic and chemical hydrolysis. A 1:1 correlation 
between enzymatic and chemical hydrolysis was also observed 
by Benkovic et al. (295) for sulfate ester hydrolysis by 
acid and an aryl sulfatase from Aspergillus oryzae. They 
interpreted this finding as indicating that the effect of 
substrate structure on the enzymatic activity is manifested 
in the velocity term, not the binding term. Our results 
suggest that the electronic nature of the substrate may also 
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Figure 7. The dependence of log (VM/KM) for calcineurin 
catalysis upon the pK. of the leaving group. The 
line shown was generated with linear regression. 
The slope of the line is -0.35. The correlation 
coefficient is -0.94. The data are from Table 
IV 
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Figure 8. Relationship of enzymatic hydrolysis to chemical 
hydrolysis. The line shown was generated with 
linear regression; the correlation coefficient is 
0.97. The slope of the line is 0.96. The data 
are from Tables IV and V 
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Figure 9. Dependence of the KM for calcineurin-catalyzed 
hydrolysis of each tyrosine phosphate derivative 
upon the pK, of the leaving group. The line 
depicted was generated for the data from the 
amino acid substrates only. The line shown was 
generated by linear regression; the crrelation 
coefficient is 0.99. The data are from Table III 
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affect the binding of substrate. As shown in Figure 9, when 
only the amino acid substrates are considered, there is a 
relationship between the KM for the amino acid substrate and 
the pKm of the leaving group. Not unexpectedly, the KM 
value for pNPP deviates greatly from this relationship. It 
is unclear that calcineurin is subject to electronic effects 
on substrate binding and catalytic specificity. 
The chemistry of phosphate esters has been extensively 
studied with a similar analysis. Table VI provides the 
values for a number of chemical reactions (301-303) as well 
as the reactions of tyrosine phosphate analogs as studied in 
the present work. The data suggest three plausible chemical 
mechanisms: 1) nucleophilic attack on the substrate by the 
enzyme with electrophilic assistance by a group on the 
enzyme, possibly bound metal ion; 2) hydrolysis of the 
substrate by HgO coordinated to Mn^" with electrophilic 
assistance by a group on the enzyme; and 3) unimolecular 
breakdown of metal coordinated substrate following proton 
transfer from the protein. 
The first mechanism involves nucleophilic attack on the 
substrate by the enzyme generating a phosphoryl-enzyme 
intermediate. A mechanism of this type is known to occur in 
the mechanism of action of alkaline and acid phosphatases 
(281,304). Nucleophilic attack on phosphate esters by a 
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TABLE VI 
Values of the Brdnsted Coefficient for Phosphate Reactions 
Reaction Ref 
Acid Catalyzed Hydrolysis 
Calcineurin Catalysis 
Monoanion Hydrolysis 
Dianion Hydrolysis 
Monoanion + Nucleophile 
Dianion + Nucleophile 
•0.33 
-0.32 
•0.32 
•1.23 
•1.00 
•1.00 
Present Study 
Present Study 
301,302 
301,302 
303 
303 
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number of different nucleophiles has been shown to have a 
= -1.00 (303). In a study of E. coli alkaline 
phosphatase, Williams et al. (305) have shown that, for a 
series of substituted phenyl phosphates, ko/Kw (VM/KM) does 
show a dependency upon the electronic characteristics of the 
substrate, whereas ko (V^) is constant. Hammett analysis of 
these data (305) yields a sensitivity lower than expected 
(corresponding to a value of less negative than 
expected) for a nucleophilic attack. This is interpreted as 
indicating electrophilic assistance in either binding of 
substrate or phosphorylation of free enzyme. Similar 
results were obtained for a number of proteolytic enzymes 
(296-299) which are known to proceed via a covalent acyl-
enzyme intermediate generated by nucleophilic attack on the 
substrate. Electrophilic assistance has also been suggested 
to have a role in aryl sulfatase action (306). The 
electrophilic assistance is presumed to come from some 
electrophilic protein group or divalent metal ion 
coordinated to the ester. The coordination results in 
increased polarization of the ester linkage. The 
phosphorous center will become electropositive, making it 
more susceptible to nucleophilic attack. It is of interest 
that calcineurin has been reported to require tightly bound 
metal for full activity (259,260,263). 
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The second model proposes a different role for metal 
ion; activation of the nucleophilicity of HgO for direct 
hydrolysis by manganese coordinated H^O on the phosphate 
ester. Coordination of HgO to Mn=~ lowers the pK« of HaO 
from 15.74 to 10.6 (307) which serves to enhance the 
nucleophilicity of the water molecule. A similar role has 
been proposed for Zn^* in the mechanism of action of 
alkaline phosphatase (269,270). Hydrolysis of phosphate 
ester dianions has been observed to proceed with a Pr.a = 
-1.23 (301). The value of 3r,a = -0.35 for calcineurin 
catalysis may be indicative of electrophilic assistance by 
the protein to the attack by water. 
Finally, Kirby and Vargolis (301) and Bunton et al. 
(302) have observed values of = -0.27 (301) and -0.32 
(302) for the hydrolysis of phosphate ester monoanions. 
This is the same value of 3t,a obtained for both the 
calcineurin- and acid-catalyzed hydrolysis observed in this 
report. Kirby and Vargolis (301) and Bunton et al. (302) 
have argued that monoanion hydrolysis proceeds via specific 
acid catalysis with protonation of the ester-linkage 
occurring in a rapid preequilibrium step followed by the 
elimination of the phenol. A similar mechanism may be 
employed in the acid-catalyzed hydrolysis of phosphate 
esters. Application of this model to calcineurin catalysis 
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would require roonoanion formation on the enzyme, possibly 
via coordination with protein or metal ion. 
One feature which distinguishes these models is the 
presence or absence of a phosphoryl-enzyme intermediate. 
The failure to detect phosphotransferase activity is 
consistent with the absence of phosphoryl-enzyme formation. 
These results suggest that direct nucleophilic attack on the 
substrate by the enzyme is not the chemical mechanism. 
These data are insufficient, however, to distinguish between 
the remaining possibilities. 
The lack of phosphotransferase activity provides 
insight into the kinetic steps in the mechanism of 
calcineurin. There are preparations of alkaline (308,309) 
and acid (296) phosphatases which do not show 
phosphotransferase activity. It has been suggested that 
this is because of a change in the rate-limiting step to 
phosphorylation of free enzyme (309). Application of these 
observations to calcineurin suggests that the rate-limiting 
step occurs prior to the release of products. Candidates 
for the rate-limiting step are binding of substrate, a 
conformational change, or cleavage of the phosphate ester 
bond. The observation that log (VM/KM) is a function of the 
pK. of the leaving group is consistent with a rate-limiting 
cleavage step provided it is accepted that the pK. of the 
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leaving group is a measure of the lability of the phosphate 
ester bond. It seems unlikely that binding of substrate 
could be rate-limiting. However, there is a relationship 
between the ability of a compound to serve as a substrate 
(reflected as VM/KM) and its KM value, again only for the 
amino acid substrates. This relationship is shown in Figure 
10. This indicates that electronic effects on substrate 
binding may explain the substrate specificity of 
calcineurin. Finally, it is possible that a conformational 
change in the enzyme might be the rate-limiting step. Our 
data are insufficient to determine the rate-limiting step. 
However, the evidence is not conclusive. Protonation and 
departure of the leaving group might still be the rate-
limiting step. 
Further information regarding the chemical mechanism of 
calcineurin can be obtained from an examination of the 
kinetic mechanism of the enzymatic reaction. Product 
inhibition studies were performed to determine the kinetic 
mechanism. Both Pi. and pNP show concentration dependent 
inhibition of the calcineurin catalyzed hydrolysis of pNPP 
as shown in Figures llA and llB. As seen, inhibition by Pj. 
occurs at much lower concentrations than for pNP. A kinetic 
study indicates that both products are competitive 
inhibitors as indicated by the Lineweaver-Burk plots shown 
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Figure 10. Relationship of KM to VM/KM^ The line shown 
was generated with linear regression for the 
amino acid substrates only. The correlation 
coefficient is -0.98. The data are from Table 
IV 
Figure 11. Inhibition of Calcineurin by Pi and pNP. 
Calcineurin was assayed in the presence of 
varied concentrations of Pi. or pNP at a 
pNPP concentration of 10 mM at 30'C. 
Activity was measured by determining the 
amount of pNP or Pi, respectively, released 
after 3 minutes. Other conditions are 
given in the "Experimental Procedures" 
section. A) Inhibition by Pi. B) 
Inhibition by pNP 
% ACTIVITY 
o 
Ot 
ACTIVITY 
> 
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> 6.0 
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Figure 12. Kinetics of the Inhibition of Calcineurin by Pi. 
Calcineurin was assayed over a range of pNPP 
concentrations from 3.3 mM to 20.0 mM in the 
presence of 0.0 (O), 1.0 (•), 2.0 (A), and 
3.0 (A) mM Pi.. Other conditions are given in 
I 
the "Experimental Procedures" section 
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15.0 
> 10.0 
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Figure 13. Kinetics of the Inhibition of Calcineurin by 
pNP. Assays were performed in the presence of 
0.0 (O), 19.4 (•), 34.0 (A), 39.0 (A), and 
48.5 (a) mM pNP over the range of pNPP 
concentrations of 8.4 mM to 50.0 mM. Other 
conditions are as given in the "Experimental 
Procedures" section 
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in Figures 12 and 13. Replots of the slope vs. [I] for both 
products are given in Figures 14A and 14B. These figures 
indicate that P^. is a linear competitive inhibitor with a Ki 
= 1.1 2 mM while pNP is observed to be a nonlinear 
competitive inhibitor (the dashed line represents an 
estimation of the lower limit of the Kx value for pNP). The 
nonlinearity prevents conclusive identification of the 
kinetic mechanism. Therefore, an analog of pNP, 
pentafluorophenol, was tested as an inhibitor. 
Pentafluorophenol resembles tetrafluorotyrosine, the 
product of the hydrolysis of tetrafluorotyrosine phosphate 
which is a substrate for calcineurin. The results of the 
inhibition study with PFP indicate that PFP is a competitive 
inhibitor, with Ki=26.4 + 3.1 mM. This is shown in Figure 
15 in the form of Lineweaver-Burk. A replot of the slope 
values from Figure 15 vs. the PFP concentration indicates 
that PFP is a linear competitive inhibitor (not shown). The 
product inhibition patterns observed are consistent with a 
rapid equilibrium random uni-bi kinetic mechanism (310). In 
the hydrolytic direction, this indicates that there is no 
preference to the order of release of products following 
hydrolysis. This is shown in Figure 16A. An ordered 
kinetic mechanism is illustrated in Figure 16B. The random 
mechanism strongly suggests that a phosphoryl-enzyme is not 
Figure 14. Replots of Slope vs. [Inhibitor] from the 
Kinetics of Inhibition of Calcineurin by P^. 
and pNP. A) Replot from the inhibition by 
Pj.. The line shown was generated by 
linear regression analysis. The 
correlation coefficient is 0.99. B) 
Replot from the inhibition by pNP. The 
dashed line represents an estimation of the 
Ki for pNP as given in Table VIII 
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Figure 15. Kinetics of the Inhibition of Calcineurin by 
PFP. Assays were performed in the presence of 
0.0 (O), 10.9 (•), 21.8 (A), 43.6 (A) mM PFP 
over the range of pNPP concentrations of 5.0 nM 
to 20.0 mM. Other conditions are as given in 
the "Experimental Procedures" section 
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Figure 16. Sequential kinetic schemes for the hydrolysis of 
phosphate esters. In these diagrams, E 
represents enzyme, ROP the substrate phosphate, 
ROH the product alcohol, and Pi inorganic 
phosphate. A) A random kinetic scheme. B) An 
ordered kinetic scheme in which Pi. is the final 
product released 
62 
generated in the mechanism of action of calcineurin. 
Coupled with the dependence of substrate hydrolysis upon the 
pK. of the phenolic leaving group and the absence of 
phosphotransferase activity at pH 7.0, this provides 
convincing evidence that calcineurin does not form a 
covalent phosphoryl-enzyme. This would be in stark contrast 
to the situation observed during the catalysis by alkaline 
(290) and acid phosphatases (289). 
As noted, pNP is a nonlinear competitive inhibitor. 
Nonlinear inhibition by pNP has been observed previously in 
the noncompetitive inhibition of an aryl sulfatase (311). 
The nonlinearity may be due to the existence of multiple 
binding sites for pNP coupled with a conformational change 
resulting in inhibition. Initial binding at a single site 
may be insufficient to generate the inhibited conformation. 
Segel (312) has described a kinetic analysis (equation 3) 
for 
log (Vi/Vo-Vi.) = -n log [I] + log Ki (3) 
multiple binding sites. Application to the inhibition of 
calcineurin by pNP indicates that 3 binding sites for pNP 
exist. Another explanation for the nonlinearity may be 
stacking interactions of pNP molecules generating a more 
potent inhibitor than a single molecule alone. With respect 
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to this point, it is interesting to note that calcineurin is 
seemingly subject to substrate inhibition in the presence of 
high pNP concentrations (see Figure 13, data for 39.0 and 
48.5 mM pNP). 
As noted. Pi inhibited calcineurin at much lower 
concentrations than does pNP. This suggests that the 
phosphoryl moiety of the substrate is of more importance in 
the binding of substrate than the phenolic function. 
However, the KM values for tyrosine phosphate derivatives 
seem to show a relationship to the pK. of the tyrosyl 
leaving group (Figure 9). It was, therefore, of interest to 
examine the potential role of the aryl function in substrate 
binding. This was performed by testing a number of 
tyrosine, serine, and threonine derivatives as inhibitors of 
calcineurin. None of the compounds tested produced 
significant inhibition. This was independent of 
substitution in the aryl ring (X=F,NOa,or F*), blockage of 
the phenolic hydroxyl (phosphate or sulfate), or blockage of 
the amino acid functional groups (N-acetyl or ester 
derivatives) as shown in Table VII. These results and the 
weak inhibition by pNP and PFP, evidenced by the values of 
Ki shown in Table VIII, are consistent with poor binding of 
the phenolic portion of the substrate. It is unclear why 
tyrosine phosphate derivatives do not inhibit very well 
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TABLE VII 
Inhibition of Calcineurin by Tyrosine Derivatives 
Addition Percent Activity" 
None 100 
(L)-Tyr 96 
(D)-Tyr 90 
(D,L)-3-F-Tyr 94 
(D,L)-2,3,4,5-F4-Tyr 98 
S-NOa-Tyr 90 
Phenylalanine 91 
Serine 95 
Threonine 82 
Tyr Ethyl Ester 95 
-Acetyl-Tyr Ethyl Ester 92 
Serine Methyl Ester 83 
Serine Phosphate 91 
Threonine Phosphate 98 
Tyrosine sulfate 91 
"Activity was determined at a pNPP concentration of 10 
raM in the absence or presence of 1 mM of each tyrosine 
analog tested as an inhibitor. The assay was performed at 
30®C for 3 minutes. Activity was determined by measuring 
the amount of Pi released. 
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TABLE VIII 
Inhibition Parameters for Product 
and Product Analogs" 
Inhibitor [Ilo.s (mM)» KI (mM)° 
pNP 31.1 >19.1^ 
PFP 40.9 21.9 
pNPS 49.4 nd® 
. HP05- 1.2 0.82 
S03- 13.9 nd-
"Calcineurin activity was measured at 10 mM pNPP under 
the conditions described in the "Procedures" section. 
•"Values of [Ilo.s were obtained by fitting the 
concentration dependent inhibition of calcineurin to a first 
order exponential equation, except for pNP for which the 
data were directly regressed. 
°The values of Ki were obtained as described in the 
"Experimental Procedures" section. 
"^As discussed in the text, pNP is a nonlinear 
inhibitor. The Ki value given is obtained the three lowest 
pNP concentrations. 
®nd = not determined. 
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because the KM values for these compounds are on the order 
of 2-6 mM (Table IV), lower than the value for pNPP of 10-15 
mM. The VM values are also much lower. These compounds 
would be expected to bind better than pNPP but not be 
hydrolyzed as quickly. 
To gain additional information concerning substrate-
directed requirements for binding, sulfate analogs of the 
substrate and product were examined in further detail as 
inhibitors. The concentration dependence of these 
inhibitors was examined, and [Ilo-s ([Ilo.a represents the 
inhibitor concentration required to achieve 50% inhibition) 
values were evaluated for these as well as the inhibitors 
utilized in the kinetic studies. These values, collected in 
Table VIII, reveal that simply an anionic center is not 
sufficient for significant inhibition. In particular, pNPS 
(monoanionic) is not a very potent inhibitor with [I]o . s  
approximately 50 mM. It should be noted that pNPS is not 
hydrolyzed by calcineurin. Sulfate ion (dianionic) is not a 
very potent inhibitor relative to phosphate ion. Sulfate 
ion does, however, more closely approach the inhibitory 
strength (compare [Ilo.s values) of phosphate than do 
the other compounds tested. Neither methyl nor ethyl 
phosphonate inhibited calcineurin to any significant degree 
over the same concentration range (not shown). This may be 
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an indication that calcineurin requires a dianion for tight 
binding. 
The inhibition studies provide strong evidence that 
calcineurin does not generate a phosphoryl-enzyme. These 
studies also provide confirmation that the rate-limiting 
step does not involve decomposition of a common intermediate 
as suggested from specificity studies (Table IV, Figure 6). 
Three alternatives readily present themselves as 
possibilities for the rate-limiting step: 1) a 
conformational change in the protein; 2) cleavage of the 
oxygen-phosphorous bond; and 3) protonation and departure of 
the phenolic leaving group. Although a relationship between 
the KM value for a tyrosine phosphate derivative and the pK. 
of the tyrosyl hydroxyl group has been observed (Figure 9), 
substrate binding can not be rate-limiting since the kinetic 
mechanism reveals the reaction to be in rapid equilibrium. 
The observed dependency of calcineurin action upon the pK» 
of the leaving group is consistent with either of the last 
two possibilities inasmuch as the pK. may reflect the 
importance of protonation of the leaving group or simply the 
lability of the ester bond. As discussed earlier, the lack 
of phosphotransferase activity suggests that the rate-
limiting step comes prior to the release of products but is 
not conclusive. Examination of the pH dependence of the 
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kinetic parameters of calcineurin with aromatic substrates 
containing leaving groups with differing pK_ values should 
provide additional insight concerning the role of 
protonation of the leaving group. 
Investigation of the pH dependence indicates that the 
maximal activity of calcineurin increases with increasing pH 
until reaching a maximum at pH 7.0. Past pH 7.0, the 
maximal activity remains constant. This occurs for both 
substrates tested, pNPP and Tyr-P, as seen in Figures 17A 
and ISA. Data analysis as described in the "Experimental 
Procedures" yields similar values for the pK. with the two 
substrates; an average pK. of 6.45 _+ 0.07 is evaluated for 
the enzyme-substrate complex. The analysis was performed 
assuming that the acidic limb of the profile is the result 
of the ionization of a single residue. The pK. evaluated is 
not due to ionization of either substrate as Tyr-P has been 
found to have a pK* value of 5.8 (313) while that of pNPP is 
5.5 (271). This indicates that a proton transfer is 
involved in catalysis by calcineurin. We suggest that this 
proton is transferred to the phenolic leaving group to 
facilitate its departure. The residue involved was not 
identified, but may be a histidine based upon the magnitude 
of the pKa value. This is not conclusive evidence because 
many functional groups have been identified in proteins with 
Figure 17. The Effect of pH on the Kinetic Parameters 
of Calcineurin with pNPP as the Substrate. 
Kinetic parameters for the hydrolysis of 
pNPP by calcineurin were evaluated as 
described in the "Experimental Procedures" 
section. The concentration of pNPP was 
varied from 3.0 to 60.0 mM. All other 
conditions and the buffers employed are 
described in the "Experimental Procedures" 
section. A) Panel A depicts the dependence 
of log VM on pH. B) Panel B shows the 
effect of pH on the log (V„/KM) term. The 
lines drawn have slopes of zero and 
negative one. For both parameters, the 
value at pH 7.0 has been set equal to one 
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Figure 18. The Effect of pH on the Kinetic Parameters 
of Calcineurin with Tyr-P as the Substrate. 
The Tyr-P concentration was varied from 3.3 
to 20.0 mM. Kinetic parameters were 
evaluated as described in the "Experimental 
Procedures" section. The buffers used are 
listed in the "Experimental Procedures" 
section. A) Panel A depicts the dependence 
of log VM on pH. B) Panel B shows the 
effect of pH on the log (VM/KM) term. The 
lines drawn have slopes of zero and 
negative one. For both parameters, the 
value obtained at pH 7.0 has been set equal 
to one 
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a pKm's of 6-7. Lacking additional evidence precludes 
assignment of the responsible group. However, it is 
noteworthy that histidine residues have been implicated in 
the binding of substrates (314) and catalysis (315) by 
alkaline phosphatase as well as in catalysis by acid 
phosphatase (316). 
Figure 3, as already discussed, indicates that the 
phosphate esters utilized in this study are not hydrolyzed 
with a constant maximal velocity. In fact, the plot is 
nonlinear with a break occurring at a pK. of the leaving 
group of approximately 7.0. This may be suggestive of a 
change in the mechanism (rate limiting) for the hydrolysis 
of Fa-Tyr-P in comparison to Tyr-P, F-Tyr-P, and pNPP. This 
is supportive of an important proton transfer from the 
enzymic group of pK. = 6.5 to the leaving group. Tyrosine, 
3-fluorotyrosine, and para-nitrophenyl phosphate all have 
phenolic groups with pK. values higher than 6.5, while the 
pK« of tetrafluorotyrosine is 5.4. Tetrafluorotyrosine does 
not require the proton transfer to be a good leaving group. 
The enzyme does not require the full use of its catalytic 
apparatus to achieve the hydrolysis of this substrate 
because of the good leaving group. 
Plots of log VM/KM VS. pH indicate a steady decline in 
the VM/KM value as the pH increases past pH 8.0 for both 
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substrates. This is shown in Figures 17B and 18B. The 
subtle differences in the plots in the high pH range are 
probably due to experimental error. Data analysis (equation 
2 ) indicates that the free enzyme has a pK« of 8.0 _+ 0.2 
consistent with the plots in Figures 17B and 188. 
Correction for ionization of the substrate yields a similar 
pK. value regardless of whether the substrate is a monoanion 
or dianion. The pK. of 8.3 (317) for cysteine most closely 
matches the value of 8.0 evaluated for calcineurin. Recent 
work by King (318) has shown that modification of 
calcineurin by sulfhydryl reagents inactivates the enzyme. 
This suggests an important role for cysteine in calcineurin 
activity. Possibly, the group identified from the log 
(VM/KM) VS. pH profiles may be water coordinated to metal 
ion. Water bound to Mn^* is known to ionize with a pK. of 
10.6 (306). It is possible that the pK» of Mn=* coordinated 
water is reduced when bound to the protein. In fact, 
Dougherty and Cleland (319) have speculated that the pK^ of 
7.8 (320) evaluated from studies of rabbit muscle pyruvate 
kinase is due to water coordinated to Mn^*. 
The apparent shift in the pH optimum when calcineurin 
is assayed in the presence of Mg=* (compare Figs. 19A and 
193) is consistent with this assignment since the pK^ of 
water bound to Mg^^ in solution is 11.4 (321) compared to 
Figure 19. The Effect of pH on the Activity of 
Calcineurin in the Presence of Mn=+ or 
Mg=*. Calcineurin activity, measured at 
the indicated pH at 30"C, was assayed by 
measuring the amount of P*. released. The 
pNPP concentration was maintained at 10 mM. 
The buffer concentration was 25 mM in all 
cases. The buffers utilized are given in 
the "Experimental Procedures" section. A) 
The effect of pH in the presence of 1 mM 
Mn^"*". B) The effect of pH in the presence 
of 20 mM Mg2* 
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the value of 10.6 for the manganese complex. The shift is 
not seemingly due to a change in the mechanism of 
calcineurin since the enzyme retains its substrate 
specificity upon the replacement of Mn^* by Mg^* as shown in 
Table IX and also fails to demonstrate phosphotransferase 
activity at pH 8.2 in the presence of Mg^*, shown in Table 
X. These results suggest that the mechanism of the enzyme 
is the same regardless of the metal ion utilized. The 
effect of substituting other metal ions for Mn^^ in the 
reaction mixture does not appear to be dependent upon the 
substrate. The effect of different metal ions are 
demonstrated in Table XI. The table indicates that 
regardless of the substrate utilized, each metal ion will 
support a certain level of calcineurin activity. This 
effect is also seemingly independent of calmodulin. 
The similarity of the pH dependent profiles for both 
pNPP and Tyr-P provides evidence that hydrolysis of the two 
substrates proceeds via the same mechanism and that 
protonation of the phenolic leaving group is not the rate-
limiting step. The dependency of V„ and V„/K„ upon the 
phenolic pK* must reflect the lability of the phosphate 
ester bond. Therefore, it seems likely that cleavage of the 
ester bond is the rate-limiting step. 
Kinetic analysis also reveals that the KM values for 
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TABLE IX 
Effect of Metal Ion on the Substrate 
Specificity of Calcineurin 
pH ( Vm ) Tyjr —I» / ( ) pigpp" (Vm/Km ) fy ir —E> / ( Vm/Km ) E>NE>r>' 
Mn 7.0 0.039 0.026 
Mg 8.2 0.054 0.140 
"The ratio of values for pNPP to Tyr-P were obtained 
from double-reciprocal plots of initial velocity data. 
Initial velocities were determined at 30*C. Mn^* was 
maintained at 1 mM while a concentration of 20 mM was 
employed. The higher concentration is required to obtain 
sufficient velocities at all substrate concentrations 
utilized. Kinetics at pH 7.0 were performed in 25 mM MOPS 
buffer; those at pH 8.2 were done in 25 mM BICINE buffer. 
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TABLE X 
Phosphotransferase Activity of Calcineurin 
Acceptor and Conditions Employed' 
Tris Tris 
[Acceptor] 1 mM Mn^* 20 mM Mg^' 
(Molar) pH 7.0 pH 8.2 
0.00 1.00 1.00 
0.10 1.03 ' 1.05 
0.20 1.09 1.03 
0.30 1.18 1.03 
"The results are presented as the ratio of the activity 
as measured by pNP release to activity as measured by P± 
release under the conditions indicated. The pNPP 
concentration was maintained at 10.0 mM. The reactions were 
done at 30'C with a reaction time of 3 minutes. 
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TABLE XI 
Metal Ion Dependence of Calcineurin" 
% Activity^ 
Me=~ Tvr-P F-Tvr-P 
+CaM 
pNPP 
-CaM 
pNPP 
Mn 100.0 100.0 100.0 100.0 
Mg 12.3 33.6 13.2 10.0 
Ca 17.1 12.2 10.7 16.7 
Ni 1135 122.9 93.1 190.5 
Zn 5.5 20.6 3.9 11.9 
Cu 40.7 19.4 35.8 29.2 
Co 40.3 51.5 20.8 37.5 
Fe 41.3 69.7 16.7 4.2 
Ba 51.5 47.4 15.8 17.9 
None 14.6 51.2 3.4 25.1 
"Activity was measured at 30*C utilizing conditions 
described under "Experimental Procedures". All metal 
ions are present at a concentration of 1 mM and were 
introduced as the chloride salt except for Fe^* which was 
the sulfate salt. 
^Activity is expressed as the percent activity obtained 
in the presence of 1 mM Mn^* for a given substrate. Only 
the hydrolysis of pNPP was studied in the absence of 
calmodulin. 
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both substrates increase with increasing pH from 
approximately 3 mM to approximately 110 mM over the entire 
range of pH studied. As mentioned, calcineurin is more 
potently inhibited by compounds containing two anion 
charges, although differences between phosphate and sulfate 
(both dianions at pH 7.0) are apparent. However, the 
increase of KM with pH suggests that the monoanion is more 
strongly bound than is the dianion. The differences between 
the binding of substrates and inhibitors may not be because 
of differences in the number of negative charges, but may be 
a result of differences in the affinity of the ligand for 
the metal ion required in calcineurin catalysis. Tighter 
binding to the metal ion may be a necessary condition for 
binding to calcineurin. 
The finding that the KM values for both substrates and 
the activity (VM) of calcineurin are increased at alkaline 
pH suggests that, while the monoanion is. bound more tightly, 
the dianion form of the substrate is hydrolyzed more 
quickly. This signifies that calcineurin may be 
transferring a proton to the substrate during the binding 
process to allow substrate binding at conditions where less 
of the monoanion exists. The effect of pH on the VM/KM term 
is consistent with this conclusion. As the group involved 
in substrate binding (pK«=8.0) becomes deprotonated, the 
82 
VM/KM term decreases, indicating that upon deprotonation, 
this group is no longer able to interact with substrate; it 
is no longer able to transfer its proton to the substrate. 
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SUMMARY 
Calcineurin has been reported to dephosphorylate a 
limited number of phosphoproteins (210-218). Analysis of 
the residue dephosphorylated indicates that the enzyme is 
active against each of the phospho-hydroxyamino acids. The 
rationale for this behavior is unknown. 
Examination of the sequences about the phosphorylated 
residue from a number of protein substrates reveals little 
conclusive evidence about specificity determinants. Table 
XII provides a schematic of the phosphorylation sites for a 
number of proteins which have been tested as substrates for 
calcineurin. The proteins have been grouped according to 
their ability to serve as a substrate for calcineurin. In 
all but one case, there is the presence of basic residues N-
terminal to the modified residue. Basic residues near the 
residue to be phosphorylated are, seemingly, very important 
for the majority of serine/threonine kinases. As a first 
estimation, the presence, number, or distance from the 
modified residue of these basic residues seems insufficient 
to determine the fate of the protein as a substrate for 
calcineurin. 
The results of this study clearly indicate that the 
substrate specificity of the low-molecular-weight 
TABLE XII 
Phosphorylation Sites of Proteins tested as Substrates for Calcineurin 
Protein Sequence' 
A) Substrates 
Phosphorylase Kinase a-subunit F R R L S I S T E S 
Myosin Light Chains A A A E G G S S N V F S M 
R II Subunit cAMP dep Kinase P G R F D R R V S V A A E 
Phosphatase Inhibitor Protein 1 R R R R P T P A T 
G-Substrate P R R K D T P A L H T S 
DARPP-32 R R R R P T P A M L F R 
Not Substrates 
Phosphorylase Kinase P-subunit A R T K R S G S V Y E P L 
Phosphorylase a E K R K Q I S V R G L A 
Glycogen Synthase Site 1 P Q W P R R A S c T S S S 
Glycogen Synthase Site 2a P L S R T L S V S S L P 
Pyruvate Kinase A G Y L R R A S L A Q L T 
Phosphofructokinase H I S R K R S G E A T V 
'"Sequences of various phosphorylation sites taken from Ingebritsen and 
Cohen (85). 
^The underlined residue is the site of modification. 
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phosphatase activity of calcineurin is dependent upon, in 
part, the electronic nature of the substrate, as measured by 
the pKm of the phenolic product. Substrates with product 
alcohols of high pK* including Ser-P, Thr-P, AMP, Glc-6-P, 
and NADP* are not dephosphorylated very well, if at all, by 
calcineurin <267). However, activated phosphate esters such 
as phosphoenolpyruvate and naphthyl phosphate can be 
dephosphorylated (262,268) quite readily by calcineurin even 
though the pK. of the resulting alcohol may be rather high 
(322). Extension of these points to protein substrates 
suggests that phosphorylated hydroxy residues (Tyr, Ser, and 
Thr) in proteins will be more readily dephosphorylated if 
the phosphorylated residue is in a microenvironment that 
will serve to increase the lability of the phosphate ester 
bond. This may explain why calcineurin is able to 
dephosphorylate proteins with phosphoseryl, phosphothreonyl, 
or phosphotyrosyl residues. 
Kinetic investigation of the enzymatic reaction reveals 
that calcineurin catalysis proceeds via a random kinetic 
mechanism. No evidence for the generation of a phosphoryl-
enzyme intermediate has been observed. Both alkaline (323) 
and acid (304) phosphatases are known to utilize an ordered 
kinetic mechanism in which a phosphoryl-enzyme is formed as 
an intermediate (289,290). The simplest model, consistent 
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with this kinetic scheme, the specificity of the enzyme, and 
the failure to observe phosphotransferase activity, suggests 
that calcineurin-catalyzed hydrolysis of phosphate esters 
proceeds via the direct transfer of the phosphoryl moiety to 
the acceptor (water) through a concerted reaction involving 
proton transfers during the binding and hydrolytic steps. 
Metal ion is suggested to serve as the means of positioning 
the substrate in the proper orientation for nucleophilic 
attack possibly by water (hydroxide) coordinated to the 
metal ion. The close spatial arrangement obtained would be 
necessary for a concerted reaction to occur. The departure 
of the leaving group is facilitated by transfer of a proton 
from some group (pK* = 6.5) on the enzyme to the leaving 
group. This occurs concomitant with the attack of the water 
molecule at the phosphorous center. This picture of the 
reaction explains the lack of a phosphoryl-enzyme intermedi­
ate, as evidenced by the lack of phosphotransferase activity 
and the random kinetic mechanism, and the importance of the 
leaving group pK«. This model is presented in Figure 20. 
As discussed, the VM observed for the hydrolysis of 
tetrafluorotyrosine phosphate does not fit the relationship 
found for the values of VM observed with the other sub­
strates. This is indicative of a change in mechanism for 
this substrate. The change in mechanism may be at the step 
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A - H  
n _ Mn ' 
Figure 20. Proposed chemical mechanism for the hydrolysis 
of low-molecular-weight phosphate esters by 
calcineurin. The model involves the attack on 
the phosphate group by a water coordinated to 
the metal ion involved in catalysis. 
Concomitant with this nucleophilic attack, a 
proton is transferred from calcineurin to the 
substrate leaving group. Refer to the text for 
further discussion 
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involving the proton transfer to the leaving group since 
tetrafluorotyrosine does require a proton transfer to be a 
good leaving group. 
Direct transfer to water is known to occur in the 
ATPase reaction catalyzed by yeast inorganic pyrophosphatase 
(324). A proton transfer in the hydrolysis reaction may 
provide the electrophilic assistance postulated previously. 
Electrophilic assistance has also been suggested to occur in 
the mechanism of action of E. coli alkaline phosphatase 
(305) and an aryl sulfatase (306). It will be of interest 
to determine if the dephosphorylation of phosphoproteins 
catalyzed by calcineurin proceeds in a similar fashion as 
the hydrolysis of nonprotein substrates. 
An analogous study (325) with the application of a 
fluorotyrosyl containing peptide as a potential substrate 
for the insulin receptor/tyrosine kinase along with a model 
acylation reaction has demonstrated that the phosphorylation 
of tyrosine residues is also affected by the chemistry about 
the phenolic hydroxyl group. The acylation of the tyrosyl 
phenolic hydroxyl group by N-acetyl imidazole (326) was only 
observed for tyrosine and fluorotyrosine. Analysis of the 
relative reactivity of these two derivatives as a function 
of pH reveals that, under conditions where the concentra­
tions of reactive species are equal (completely deprotonated 
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hydroxyl), then tyrosine is 17-fold more reactive than is 3-
fluorotyrosine. This is consistent with the expected 
Brdnsted relationship. Examination of the phosphorylation 
of peptides incorporating fluorotyrosine derivatives, 
suggests that the protonation state of the phenolic hydroxyl 
group is an important feature involved in the regulation of 
tyrosine phosphorylation. The fluorotyrosine-containing 
peptide is phosphorylated with only a slightly lower KM 
value, but with a 2.5-fold lower VM value than is the 
tyrosine-containing peptide. The simplest model to explain 
these observations, in comparison with the chemical acyla-
tion, provides that the substrate hydroxyl group is 
deprotonated on the enzyme prior to the phosphorylation 
event. 
The importance of the hydroxyl protonation state is 
further supported by studies of the phosphorylation of 
peptides in which the tyrosine has been replaced with a 
serine or threonine residues (327). The substituted 
peptides cannot be phosphorylated by the insulin 
receptor/kinase, but do serve as competitive inhibitors 
suggesting that the change does not affect the binding 
process. The simplest explanation would suggest that the 
high pKa of the serine or threonine hydroxyl prevents the 
phosphorylation reaction. However, it is possible that some 
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other feature of the tyrosine side chain may be the 
determining factor. 
In parallel with the results obtained for the hydroly­
sis of tyrosine phosphate derivatives by calcineurin, it 
seems clear that the modification of tyrosine residues is 
highly dependent upon the chemistry at the specific site of 
modification. It is obvious that this, in turn, will be 
affected by the environment in which the residue is found. 
This study represents the first detailed examination of 
the chemical mechanism of action of any phosphoprotein 
specific phosphatase. These studies also demonstrate the 
utility of fluorinated derivatives in the examination of 
bioorganic reaction mechanisms as well as the application of 
physical organic chemistry to an enzymatic reaction. 
Moreover, these studies provide an initial examination of 
the chemical features involved in the phosphorylation-
dephosphorylation of tyrosine residues in proteins. 
A number of additional experiments suggest themselves 
as tests of the putative mechanism. Specifically, determin­
ation of the rate-limiting step and the stereochemistry of 
the reaction would provide important information for the 
development of any mechanism for calcineurin. Conclusive 
evidence is required relative to the formation of a covalent 
intermediate. Finally, a more complete explanation for the 
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activity of calcineurin toward phosphoseryl-, phosphothreo-
nyl-, and phosphotyrosyl-containing phosphoproteins remains 
to be advanced. 
The earlier discussion of the possible rate-limiting 
steps resulted in the discarding of either binding of 
substrate or the protonation and departure of the leaving 
group as the rate-limiting step for the hydrolysis of low-
molecular-weight substrates. Cleavage of the phosphate 
ester bond or some conformational change in the enzyme were 
left as choices. Examination of the solvent isotope effect 
would provide information concerning the role of water in 
the reaction, possibly in the cleavage step. 
Although calcineurin is active toward a number of 
phosphoseryl- and phosphothreonyl-containing phospho­
proteins, the enzyme is inactive toward the free amino 
acids, phosphoserine or phosphothreonine. We have suggested 
(272) that the lack of activity is a result of the high pK» 
in the resulting product alcohol (pK«=13.6 for serine 
<328)). 2,2,2-trifluoroethanol has a pK* of 12.4, between 
the values for tyrosine and serine. Synthesis of 2,2,2-
trifluoroethyl phosphate may provide a useful substrate, if 
hydrolyzed, to obtain additional information of the effect 
of the pK. of an aliphatic alcohol. This compound may also 
serve as a model for the dephosphorylation of phosphoseryl 
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residues in substrate proteins. 
The question of whether calcineurin catalysis involves 
the formation of a phosphoryl-enzyme remains inconclusive. 
All kinetic evidence obtained argues against the formation 
of a phosphoryl-enzyme. However, it is possible that a 
phosphoryl-enzyme may be produced upon cleavage of the 
phosphate ester bond without the release of the phenolic 
leaving group. This group might remain noncovalently 
associated with the protein until hydrolysis of the phospho­
ryl -enzyme occurs with the concomitant release of both 
products. This mechanism would also demonstrate random 
order kinetics, but actually be an ordered mechanism. The 
differetiation between these two situations could be 
approached in two ways. Incubation of the enzyme with 
either or ^^Pi-labelled Substrate might achieve the 
radiolabelling of the enzyme. Both of these methods have 
demonstrated labelling of alkaline phosphatase (329,330). 
Simply the isolation of a ^^Pi-labelled protein would 
provide strong evidence for a phosphoryl-enzyme 
intermediate. However, if this intermediate does form, no 
evidence concerning its chemical properties, in particular 
iiis lifetime presently exists. A second approach to this 
feature of the mechanism would be the examination of the 
stereochemistry (331) of the hydrolysis reaction employing 
93 
the chiral compound, [,^^0]-para-nitrophenyl 
phosphorothioate. Hydrolysis of this compound with 
retention of its stereochemistry would reflect an equal 
number of substitution reactions consistent with the 
hydrolysis of a phosphoryl-enzyme. Inversion of the 
stereochemistry during hydrolysis would be indicative of an 
odd number of transfer steps consistent with the direct 
hydrolysis of the ester. An odd number of transfers is also 
consistent with the formation of two different phosphoryl-
enzyme forms prior to the hydrolysis of the intermediate by 
water. This chiral compound is known to be a substrate for 
the alkaline phosphatase (332). All alkaline and acid 
phosphatases, for which the stereochemistry has been 
determined (333), show an inversion of stereochemistry and 
have been shown to proceed via a phosphoryl-enzyme 
intermediate. No information has been acquired for any 
phosphoprotein-specific phosphatase. 
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